Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board ...

Greetings, and welcome to the Q3 fiscal year 2025 ResMed earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) And also, please note this ...

It's decluttering season—here's how to know when you probably shouldn't put the time and effort into listing an item.

Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will ...

ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...

today announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21, 2025. In this role, Schwartz will lead Resmed's global investor relations function and ...

Former Illumina, MSCI, and Moody's executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...